Cargando…
Targeting IAP proteins in combination with radiotherapy
The efficacy of radiotherapy critically depends on the activation of intrinsic cell death programs in cancer cells. This implies that evasion of cell death, a hallmark of human cancers, can contribute to radioresistance. Therefore, novel strategies to reactivate cell death programs in cancer cells a...
Autor principal: | Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436972/ https://www.ncbi.nlm.nih.gov/pubmed/25927408 http://dx.doi.org/10.1186/s13014-015-0399-3 |
Ejemplares similares
-
IAP proteins as targets for drug development in oncology
por: Dubrez, Laurence, et al.
Publicado: (2013) -
Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer
por: Vaux, David L
Publicado: (2009) -
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
por: Rathore, Rama, et al.
Publicado: (2017) -
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment
por: Cossu, Federica, et al.
Publicado: (2019) -
Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)